The World Health Organization (WHO) Technical Advisory Group on Innovations in Male Circumcision (TAG) met at WHO headquarters in Geneva in January 2013 to review the clinical performance of two male circumcision devices (PrePex and ShangRing) as part of the product review in WHO' programme for prequalification of male circumcision devices. The discussions described in this meeting report also addressed programmatic considerations for guidance under development on the use of devices, information gaps, and research needs.